Molecular study of vitamin D metabolism-related single nucleotide polymorphisms in cardiovascular risk: a case-control study
Authors:
- José María Gálvez-NavasJosé María Gálvez-Navas
- Noelia Márquez-PeteNMNoelia Márquez-Pete
- Madalena Paiva-ChavesMPMadalena Paiva-Chaves
- Susana Rojo-TolosaSRSusana Rojo-Tolosa
- Laura Elena Pineda-LancherosLaura Elena Pineda-Lancheros
- Yasmin CuraYCYasmin Cura
- Cristina Membrive-JiménezCristina Membrive-Jiménez
- Luciana Maria Marangoni-IgleciasLMLuciana Maria Marangoni-Iglecias
- Andrea Fernández-AlonsoAFAndrea Fernández-Alonso
- Mcarmen Ramírez-TortosaMRMcarmen Ramírez-Tortosa
- Cristina Pérez-RamírezCPCristina Pérez-Ramírez
- Alberto Jiménez-MoralesAJAlberto Jiménez-Morales
Open Access
- 16 April 2025
- journal article
- research article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 81 (2) , 347-357
Abstract
Cardiovascular diseases (CVDs) constitute a major global health problem, being the leading cause of death. Several risk factors for CVDs have been identified, including tobacco use, unhealthy diet, and physical inactivity. However, the role of genetic factors in CVDs remains unclear. Recent studies suggest that vitamin D deficiency is associated with an increased risk of CVDs. Therefore, the aim of this study is to assess the impact of 13 single nucleotide polymorphisms (SNPs) located in genes involved in vitamin D metabolism (VDR, GC, CYP27B1, CYP2R1, and CYP24A1) on the risk of developing CVDs. A retrospective case-control study was conducted in 766 Caucasian individuals from southern Spain: 383 diagnosed with CVDs and 383 without cardiovascular complications, matched based on age and sex. The 13 SNPs were identified by real-time PCR using TaqMan™ probes at the Virgen de las Nieves University Hospital and the University of Granada. According to statistical analysis the allele G and genotype GG of the SNP CYP2R1 rs10741657 and the allele C and CC genotype of the SNP CYP27B1 rs3782130 are associated with a decreased risk of CVDs and diabetes in three of the five heritage models studied. Thus, it can be concluded that CYP2R1 rs10741657 and CYP27B1 rs3782130 could be used as risk biomarkers for CVDs in the future, although studies with a larger number of participants are needed.Keywords
Funding Information
- Instituto de Salud Carlos III (PT13/0010/0039)
This publication has 41 references indexed in Scilit:
- Vitamin D and cardiovascular disease risk. A literature overviewMolecular Biology Reports, 2022
- Circulating 25-hydroxy-vitamin D and the risk of cardiovascular diseases. Systematic review and meta-analysis of prospective cohort studiesNutrition, Metabolism and Cardiovascular Diseases, 2021
- Vitamin D Receptor (VDR) Gene Polymorphisms and Risk of Coronary Artery Disease (CAD): Systematic Review and Meta-analysisBiochemical Genetics, 2021
- Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseasesMolecular Biology Reports, 2019
- Vitamin D Metabolism and the Implications for Atherosclerosis2017
- Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery diseaseNutrition, Metabolism and Cardiovascular Diseases, 2017
- Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment StudyJAMA Cardiology, 2017
- Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart FailureJACC: Heart Failure, 2015
- Vitamin D Status Is Associated With Arterial Stiffness and Vascular Dysfunction in Healthy HumansJACC, 2011
- Prevalence of Vitamin D Deficiency in Patients With Acute Myocardial InfarctionThe American Journal of Cardiology, 2011